Guardant Health’s Shield blood-based colorectal cancer test was recently included in updated National Comprehensive Cancer Network screening guidelines. A new national survey of Americans aged 45 and ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of a new national ...

Guardant Health Inc. company and executive profile by Barron's. View the latest GH company infomation and executive bios.

Guardant Health (NASDAQ: GH) is on the rise, in more ways than one. Shares of the precision oncology company have skyrocketed over the last six months. Guardant Health has also chalked up several key ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 1:00 PM EDTCompany ParticipantsAmirAli Talasaz - Co-CEO ...

NASCAR fans at this weekend’s Pennzoil 400 will have the opportunity to learn more about colorectal cancer screening.

With colon cancer deaths rising among younger adults and millions of eligible Americans skipping their colonoscopies, Guardant Health is taking its Shield blood test on the road in hopes of tackling ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it entered into privately negotiated exchange ...

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, today announced the pricing of its upsized offering of $350.0 million aggregate principal amount ...

The Tuscarawas County Health Department is offering free colorectal cancer screenings and walk-in A1C testing this month.

Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced its intention to offer $300.0 million aggregate principal amount of convertible senior ...

Guardant Health hasn't scheduled its Q4 update yet but will likely report results by Feb. 19, 2026. The precision oncology company has had a lot of good news recently. However, the investment thesis ...